首页 > 最新文献

Pigment Cell & Melanoma Research最新文献

英文 中文
Mouse Tail-Skin Dissociation and Preparation of Live Single-Cell Suspension for Downstream Analysis of Melanocytes 小鼠尾皮解离及单细胞活悬液制备用于黑素细胞下游分析。
IF 3.9 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-12-03 DOI: 10.1111/pcmr.13216
Vipin Shankar Chelakkot, Kiara Thomas, Leen Hussein, Todd Romigh, Ying Ni, Joshua Arbesman

Isolating high-quality viable single cells from mouse tail skin, a well-established model for studying skin cells and melanoma pathogenesis, is challenging due to the presence of dense connective tissue and hair follicles. Single-cell RNA sequencing (scRNA-seq) is a powerful tool for studying skin cell heterogeneity. However, the lack of a robust protocol for the efficient generation of highly viable single-cell suspension from mouse tail skin has limited its application for studying melanocyte-interacting cells and characterizing the melanocyte niche. We developed a robust protocol for generating highly viable single-cell suspensions from mouse tail skin, facilitating single-cell transcriptomic profiling of keratinocytes, melanocytes, and fibroblasts. We demonstrate the successful isolation of melanocytes and other melanocyte-interacting cells using our protocol and a proof-of-concept scRNA-seq study for interrogating the melanocyte niche. Our protocol employs a two-stage enzyme dissociation step, followed by debris removal and subsequent live cell enrichment, to obtain a single-cell suspension with high cell viability. This straightforward protocol enables the isolation of viable single cells from mouse tail skin for downstream scRNA-seq studies. Further, this approach allows comprehensive analysis of the melanocyte niche and melanocyte-interacting cells, potentially aiding in identifying the melanoma cell of origin.

作为研究皮肤细胞和黑色素瘤发病机制的成熟模型,从小鼠尾部皮肤中分离出高质量的存活单细胞具有挑战性,因为存在致密的结缔组织和毛囊。单细胞RNA测序(scRNA-seq)是研究皮肤细胞异质性的有力工具。然而,缺乏从小鼠尾部皮肤中高效生成高存活率单细胞悬液的可靠方案,限制了其在研究黑素细胞相互作用细胞和表征黑素细胞生态位方面的应用。我们开发了一种强大的方案,用于从小鼠尾部皮肤中产生高存活率的单细胞悬浮液,促进角化细胞、黑素细胞和成纤维细胞的单细胞转录组谱分析。我们展示了使用我们的方案成功分离黑素细胞和其他与黑素细胞相互作用的细胞,并进行了概念验证的scRNA-seq研究,以询问黑素细胞生态位。我们的方案采用两阶段酶解步骤,然后去除碎片和随后的活细胞富集,以获得具有高细胞活力的单细胞悬浮液。这种简单的方案可以从小鼠尾部皮肤中分离出有活力的单细胞,用于下游scRNA-seq研究。此外,这种方法允许对黑素细胞生态位和黑素细胞相互作用细胞进行全面分析,可能有助于识别黑色素瘤细胞的起源。
{"title":"Mouse Tail-Skin Dissociation and Preparation of Live Single-Cell Suspension for Downstream Analysis of Melanocytes","authors":"Vipin Shankar Chelakkot,&nbsp;Kiara Thomas,&nbsp;Leen Hussein,&nbsp;Todd Romigh,&nbsp;Ying Ni,&nbsp;Joshua Arbesman","doi":"10.1111/pcmr.13216","DOIUrl":"10.1111/pcmr.13216","url":null,"abstract":"<div>\u0000 \u0000 <p>Isolating high-quality viable single cells from mouse tail skin, a well-established model for studying skin cells and melanoma pathogenesis, is challenging due to the presence of dense connective tissue and hair follicles. Single-cell RNA sequencing (scRNA-seq) is a powerful tool for studying skin cell heterogeneity. However, the lack of a robust protocol for the efficient generation of highly viable single-cell suspension from mouse tail skin has limited its application for studying melanocyte-interacting cells and characterizing the melanocyte niche. We developed a robust protocol for generating highly viable single-cell suspensions from mouse tail skin, facilitating single-cell transcriptomic profiling of keratinocytes, melanocytes, and fibroblasts. We demonstrate the successful isolation of melanocytes and other melanocyte-interacting cells using our protocol and a proof-of-concept scRNA-seq study for interrogating the melanocyte niche. Our protocol employs a two-stage enzyme dissociation step, followed by debris removal and subsequent live cell enrichment, to obtain a single-cell suspension with high cell viability. This straightforward protocol enables the isolation of viable single cells from mouse tail skin for downstream scRNA-seq studies. Further, this approach allows comprehensive analysis of the melanocyte niche and melanocyte-interacting cells, potentially aiding in identifying the melanoma cell of origin.</p>\u0000 </div>","PeriodicalId":219,"journal":{"name":"Pigment Cell & Melanoma Research","volume":"38 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142764905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Ball Python Colour Morph Implicates MC1R in Melanophore–Xanthophore Distribution and Pattern Formation 一种球蟒的颜色形态与MC1R在黑素团-黄素团分布和模式形成中的关系。
IF 3.9 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-11-28 DOI: 10.1111/pcmr.13215
Alan Garcia-Elfring, Heather L. Roffey, Jaren M. Abergas, Jurgen Wuyts, Andrew P. Hendry, Athanasia C. Tzika, Rowan D. H. Barrett

Reptiles showcase an extensive array of skin colours and patterns, yet little is known about the genetics of reptile colouration. Here, we investigate the genetic basis of the Clown colour morph found in captive-bred ball pythons (Python regius) to study skin pigmentation and patterning in snakes. We obtained samples by crowdsourcing shed skin from commercial breeders and hobbyists. We applied a case–control design, whole-genome pool sequencing, variant annotation, histological analyses, and electron microscopy imaging. We identified a missense mutation in a transmembrane region of the melanocortin-1 receptor (MC1R) associated with the Clown phenotype. In classic avian and mammalian model species, MC1R is known for controlling the type and amount of melanin produced. In contrast, our results suggest that MC1R signalling might play a key role in pattern formation in ball pythons, affecting xanthophore–melanophore distribution. This work highlights the varied functions of MC1R across different vertebrate lineages and promotes a novel model system to study reptile colouration.

爬行动物展示了一系列广泛的皮肤颜色和图案,但关于爬行动物颜色的遗传学知之甚少。在这里,我们研究了在人工饲养的球蟒(Python regius)中发现的小丑颜色形态的遗传基础,以研究蛇的皮肤色素沉着和图案。我们通过众包商业育种者和爱好者的蜕皮获得样本。我们采用病例对照设计、全基因组池测序、变异注释、组织学分析和电子显微镜成像。我们在与小丑表型相关的黑素皮质素-1受体(MC1R)的跨膜区域发现了一个错义突变。在经典的鸟类和哺乳动物模型物种中,MC1R以控制黑色素的类型和数量而闻名。相反,我们的研究结果表明,MC1R信号可能在球蟒的模式形成中发挥关键作用,影响黄细胞-黑细胞的分布。这项工作强调了MC1R在不同脊椎动物谱系中的不同功能,并促进了一种新的模型系统来研究爬行动物的着色。
{"title":"A Ball Python Colour Morph Implicates MC1R in Melanophore–Xanthophore Distribution and Pattern Formation","authors":"Alan Garcia-Elfring,&nbsp;Heather L. Roffey,&nbsp;Jaren M. Abergas,&nbsp;Jurgen Wuyts,&nbsp;Andrew P. Hendry,&nbsp;Athanasia C. Tzika,&nbsp;Rowan D. H. Barrett","doi":"10.1111/pcmr.13215","DOIUrl":"10.1111/pcmr.13215","url":null,"abstract":"<div>\u0000 \u0000 <p>Reptiles showcase an extensive array of skin colours and patterns, yet little is known about the genetics of reptile colouration. Here, we investigate the genetic basis of the Clown colour morph found in captive-bred ball pythons (<i>Python regius</i>) to study skin pigmentation and patterning in snakes. We obtained samples by crowdsourcing shed skin from commercial breeders and hobbyists. We applied a case–control design, whole-genome pool sequencing, variant annotation, histological analyses, and electron microscopy imaging. We identified a missense mutation in a transmembrane region of the <i>melanocortin-1 receptor</i> (<i>MC1R</i>) associated with the Clown phenotype. In classic avian and mammalian model species, MC1R is known for controlling the type and amount of melanin produced. In contrast, our results suggest that MC1R signalling might play a key role in pattern formation in ball pythons, affecting xanthophore–melanophore distribution. This work highlights the varied functions of MC1R across different vertebrate lineages and promotes a novel model system to study reptile colouration.</p>\u0000 </div>","PeriodicalId":219,"journal":{"name":"Pigment Cell & Melanoma Research","volume":"38 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142749525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Variants in Medium and Low Penetrance Predisposing Genes in a Hungarian Malignant Melanoma Cohort With Increased Risk 匈牙利恶性黑色素瘤队列中中外显率和低外显率易感基因的新变异与风险增加。
IF 3.9 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-11-28 DOI: 10.1111/pcmr.13214
Barbara Anna Bokor, Aliasgari Abdolreza, Flóra Kaptás, Margit Pál, Zita Battyani, Márta Széll, Nikoletta Nagy

Both germline and somatic variants contribute to the genetic background and pathogenesis of melanoma. Germline variants include the presence of rare pathogenic or likely pathogenic variants of high, medium, and low penetrance melanoma-predisposing genes. Rare variants of high penetrance melanoma-predisposing genes are associated with melanoma development, whereas the medium and low penetrance predisposing genes can significantly increase melanoma risk. In this study, we clarified the germline genetic background of a Hungarian melanoma cohort (n = 17). Using a gene panel of 30 melanoma-predisposing genes, germline genetic variants were identified in 10 of the 17 patients (58.82%). A novel, likely pathogenic, missense variant (p.Y143C) in a medium penetrance melanoma-predisposing gene, melanocortin 1 receptor gene (MC1R), and two novel, likely pathogenic nonsense variants in low penetrance genes, p.Q218Ter in caspase 8 (CASP8) and p.Q40Ter in the fat mass- and obesity-associated (FTO) gene were detected. This study highlights the importance of elucidating the germline genetic background of melanoma, which may improve prediction of individual risk and the risk of family members and to optimize preventive, screening, and therapeutic measures for each patient and melanoma-prone families.

种系和体细胞变异都有助于黑色素瘤的遗传背景和发病机制。种系变异包括高、中、低外显率黑色素瘤易感基因的罕见致病性或可能致病性变异。高外显率易患黑色素瘤基因的罕见变异与黑色素瘤的发展有关,而中外显率和低外显率易患基因可显著增加黑色素瘤的风险。在这项研究中,我们澄清了匈牙利黑色素瘤队列(n = 17)的种系遗传背景。使用30个黑色素瘤易感基因的基因面板,在17例患者中有10例(58.82%)确定了种系遗传变异。在中等外显率的黑色素瘤易感基因黑素皮质素1受体基因(MC1R)中检测到一种新的、可能致病的错义变异(p.Y143C),以及在低外显率基因中检测到两种新的、可能致病的无义变异,即半胱天冬酶8 (CASP8)中的p.p q218ter和脂肪量和肥胖相关(FTO)基因中的p.p q40ter。这项研究强调了阐明黑色素瘤的种系遗传背景的重要性,这可能会提高个体风险和家庭成员风险的预测,并优化每个患者和黑色素瘤易发家庭的预防、筛查和治疗措施。
{"title":"Novel Variants in Medium and Low Penetrance Predisposing Genes in a Hungarian Malignant Melanoma Cohort With Increased Risk","authors":"Barbara Anna Bokor,&nbsp;Aliasgari Abdolreza,&nbsp;Flóra Kaptás,&nbsp;Margit Pál,&nbsp;Zita Battyani,&nbsp;Márta Széll,&nbsp;Nikoletta Nagy","doi":"10.1111/pcmr.13214","DOIUrl":"10.1111/pcmr.13214","url":null,"abstract":"<div>\u0000 \u0000 <p>Both germline and somatic variants contribute to the genetic background and pathogenesis of melanoma. Germline variants include the presence of rare pathogenic or likely pathogenic variants of high, medium, and low penetrance melanoma-predisposing genes. Rare variants of high penetrance melanoma-predisposing genes are associated with melanoma development, whereas the medium and low penetrance predisposing genes can significantly increase melanoma risk. In this study, we clarified the germline genetic background of a Hungarian melanoma cohort (<i>n</i> = 17). Using a gene panel of 30 melanoma-predisposing genes, germline genetic variants were identified in 10 of the 17 patients (58.82%). A novel, likely pathogenic, missense variant (p.Y143C) in a medium penetrance melanoma-predisposing gene, <i>melanocortin 1 receptor gene</i> (<i>MC1R</i>), and two novel, likely pathogenic nonsense variants in low penetrance genes, p.Q218Ter in caspase 8 (<i>CASP8</i>) and p.Q40Ter in the fat mass- and obesity-associated (<i>FTO</i>) gene were detected. This study highlights the importance of elucidating the germline genetic background of melanoma, which may improve prediction of individual risk and the risk of family members and to optimize preventive, screening, and therapeutic measures for each patient and melanoma-prone families.</p>\u0000 </div>","PeriodicalId":219,"journal":{"name":"Pigment Cell & Melanoma Research","volume":"38 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142749534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer 探讨皮肤黑色素瘤和胰腺癌的常见突变景观。
IF 3.9 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-11-28 DOI: 10.1111/pcmr.13210
Elisabetta Broseghini, Federico Venturi, Giulia Veronesi, Biagio Scotti, Marina Migliori, Desy Marini, Claudio Ricci, Riccardo Casadei, Manuela Ferracin, Emi Dika

Cutaneous melanoma (CM) and pancreatic cancer are aggressive tumors whose incidences are rapidly increasing in the last years. This review aims to provide a complete and update description about mutational landscape in CM and pancreatic cancer, focusing on similarities of these two apparently so different tumors in terms of site, type of cell involved, and embryonic origin. The familial forms of CM and pancreatic cancers are often characterized by a common mutated gene, namely CDKN2A. In fact, a germline mutation in CDKN2A gene can be responsible for the development of the familial atypical multiple mole and melanoma syndrome (FAMMM), which is characterized by melanomas and pancreatic cancer development. Sporadic melanoma and pancreatic cancer showed different key-driven genes. The open-access resource cBioPortal has been explored to deepen and investigate the common mutational landscape of these two tumors. We investigated the common mutated genes found in both melanoma and pancreatic cancer with a frequency of at least 5% of tested patients and copy number alterations with a frequency of at least of 3%. Data showed that 18 mutated genes and 3 copy number alterations are present in both melanoma and pancreatic cancers types. Since we found two patients that developed both melanoma and pancreatic cancer, we compared mutation landscape between the two tumors and identified a pathogenic variant in BRCA2 gene. This review gives valuable insights into the genetic underpinnings of melanoma and pancreatic cancer, urging the continued exploration and research of new genetic biomarkers able to identify patients and families at high risk of developing both cancers and to address to screening and to an effective clinical management of the patient.

皮肤黑色素瘤(CM)和胰腺癌是侵袭性肿瘤,其发病率在过去几年中迅速增加。本文旨在对CM和胰腺癌的突变图景提供完整和最新的描述,重点介绍这两种明显不同的肿瘤在部位、涉及的细胞类型和胚胎起源方面的相似性。CM和胰腺癌的家族性形式通常以一个共同的突变基因CDKN2A为特征。事实上,CDKN2A基因的种系突变可能导致家族性非典型多发性痣和黑色素瘤综合征(FAMMM)的发展,其特征是黑色素瘤和胰腺癌的发展。散发性黑色素瘤和胰腺癌显示出不同的关键驱动基因。开放获取资源cBioPortal已被探索以深化和研究这两种肿瘤的共同突变景观。我们研究了在黑色素瘤和胰腺癌中发现的常见突变基因,其频率至少为5%,拷贝数改变的频率至少为3%。数据显示,在黑色素瘤和胰腺癌类型中都存在18个突变基因和3个拷贝数改变。由于我们发现了两名同时患黑色素瘤和胰腺癌的患者,我们比较了两种肿瘤之间的突变情况,并确定了BRCA2基因的致病变异。这篇综述为黑色素瘤和胰腺癌的遗传基础提供了有价值的见解,敦促继续探索和研究新的遗传生物标志物,能够识别患这两种癌症的高风险患者和家庭,并解决患者的筛查和有效的临床管理。
{"title":"Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer","authors":"Elisabetta Broseghini,&nbsp;Federico Venturi,&nbsp;Giulia Veronesi,&nbsp;Biagio Scotti,&nbsp;Marina Migliori,&nbsp;Desy Marini,&nbsp;Claudio Ricci,&nbsp;Riccardo Casadei,&nbsp;Manuela Ferracin,&nbsp;Emi Dika","doi":"10.1111/pcmr.13210","DOIUrl":"10.1111/pcmr.13210","url":null,"abstract":"<p>Cutaneous melanoma (CM) and pancreatic cancer are aggressive tumors whose incidences are rapidly increasing in the last years. This review aims to provide a complete and update description about mutational landscape in CM and pancreatic cancer, focusing on similarities of these two apparently so different tumors in terms of site, type of cell involved, and embryonic origin. The familial forms of CM and pancreatic cancers are often characterized by a common mutated gene, namely <i>CDKN2A</i>. In fact, a germline mutation in <i>CDKN2A</i> gene can be responsible for the development of the familial atypical multiple mole and melanoma syndrome (FAMMM), which is characterized by melanomas and pancreatic cancer development. Sporadic melanoma and pancreatic cancer showed different key-driven genes. The open-access resource cBioPortal has been explored to deepen and investigate the common mutational landscape of these two tumors. We investigated the common mutated genes found in both melanoma and pancreatic cancer with a frequency of at least 5% of tested patients and copy number alterations with a frequency of at least of 3%. Data showed that 18 mutated genes and 3 copy number alterations are present in both melanoma and pancreatic cancers types. Since we found two patients that developed both melanoma and pancreatic cancer, we compared mutation landscape between the two tumors and identified a pathogenic variant in <i>BRCA2</i> gene. This review gives valuable insights into the genetic underpinnings of melanoma and pancreatic cancer, urging the continued exploration and research of new genetic biomarkers able to identify patients and families at high risk of developing both cancers and to address to screening and to an effective clinical management of the patient.</p>","PeriodicalId":219,"journal":{"name":"Pigment Cell & Melanoma Research","volume":"38 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11681848/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142749529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State 脂滴蛋白 DHRS3 是黑色素瘤细胞状态的调控因子
IF 3.9 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-31 DOI: 10.1111/pcmr.13208
Eleanor Johns, Yilun Ma, Pakavarin Louphrasitthiphol, Christopher Peralta, Miranda V. Hunter, Jeremy H. Raymond, Henrik Molina, Colin R. Goding, Richard M. White

Lipid droplets are fat storage organelles composed of a protein envelope and lipid-rich core. Regulation of this protein envelope underlies differential lipid droplet formation and function. In melanoma, lipid droplet formation has been linked to tumor progression and metastasis, but it is unknown whether lipid droplet proteins play a role. To address this, we performed proteomic analysis of the lipid droplet envelope in melanoma. We found that lipid droplet proteins were differentially enriched in distinct melanoma states; from melanocytic to undifferentiated. DHRS3, which converts all-trans-retinal to all-trans-retinol, is upregulated in the MITFLO/undifferentiated/neural crest-like melanoma cell state and reduced in the MITFHI/melanocytic state. Increased DHRS3 expression is sufficient to drive MITFHI/melanocytic cells to a more undifferentiated/invasive state. These changes are due to retinoic acid-mediated regulation of melanocytic genes. Our data demonstrate that melanoma cell state can be regulated by expression of lipid droplet proteins which affect downstream retinoid signaling.

脂滴是一种脂肪储存细胞器,由蛋白质包膜和富含脂质的核心组成。对这种蛋白质包膜的调节是脂滴形成和功能差异的基础。在黑色素瘤中,脂滴的形成与肿瘤的进展和转移有关,但脂滴蛋白是否在其中发挥作用尚不清楚。为了解决这个问题,我们对黑色素瘤的脂滴包膜进行了蛋白质组学分析。我们发现,脂滴蛋白在不同的黑色素瘤状态(从黑色素细胞瘤到未分化瘤)中富集程度不同。DHRS3能将全反式视黄醛转化为全反式视黄醇,它在MITFLO/未分化/神经嵴样黑色素瘤细胞状态中上调,而在MITFHI/黑色素细胞状态中降低。DHRS3 表达的增加足以使 MITFHI/黑素细胞细胞进入未分化/侵袭状态。这些变化是由于视黄酸介导的黑色素细胞基因调控所致。我们的数据表明,黑色素瘤细胞的状态可以通过脂滴蛋白的表达来调节,而脂滴蛋白的表达会影响下游的视黄酸信号转导。
{"title":"The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State","authors":"Eleanor Johns,&nbsp;Yilun Ma,&nbsp;Pakavarin Louphrasitthiphol,&nbsp;Christopher Peralta,&nbsp;Miranda V. Hunter,&nbsp;Jeremy H. Raymond,&nbsp;Henrik Molina,&nbsp;Colin R. Goding,&nbsp;Richard M. White","doi":"10.1111/pcmr.13208","DOIUrl":"10.1111/pcmr.13208","url":null,"abstract":"<div>\u0000 \u0000 <p>Lipid droplets are fat storage organelles composed of a protein envelope and lipid-rich core. Regulation of this protein envelope underlies differential lipid droplet formation and function. In melanoma, lipid droplet formation has been linked to tumor progression and metastasis, but it is unknown whether lipid droplet proteins play a role. To address this, we performed proteomic analysis of the lipid droplet envelope in melanoma. We found that lipid droplet proteins were differentially enriched in distinct melanoma states; from melanocytic to undifferentiated. DHRS3, which converts all-trans-retinal to all-trans-retinol, is upregulated in the MITF<sup>LO</sup>/undifferentiated/neural crest-like melanoma cell state and reduced in the MITF<sup>HI</sup>/melanocytic state. Increased DHRS3 expression is sufficient to drive MITF<sup>HI</sup>/melanocytic cells to a more undifferentiated/invasive state. These changes are due to retinoic acid-mediated regulation of melanocytic genes. Our data demonstrate that melanoma cell state can be regulated by expression of lipid droplet proteins which affect downstream retinoid signaling.</p>\u0000 </div>","PeriodicalId":219,"journal":{"name":"Pigment Cell & Melanoma Research","volume":"38 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142542417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
UVA Irradiation Promotes Melanoma Cell Proliferation Mediated by OPN3 Independently of ROS Production 紫外线照射促进黑色素瘤细胞增殖与 ROS 生成无关,由 OPN3 介导。
IF 3.9 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-30 DOI: 10.1111/pcmr.13206
Yulei Zhang, Wen Zeng, Wei Zhang, Yu Wang, Shuqi Jin, Ting Liu, Huanhuan Luo, Hongguang Lu

UVA radiation, a primary risk factor in melanoma progression, partly acts through the mediation of reactive oxygen species (ROS). The role of ROS in driving cutaneous melanoma toward an invasive phenotype and whether it occurs through opsins (OPNs), which are photosensitive G protein-coupled receptors, is not fully understood. This study focuses on the impact of UVA radiation on melanoma cell proliferation, with a special emphasis on OPN3. Investigating the biphasic response to various UVA doses (0.75–9 J/cm2) in A375 and MV3 cell lines, and using EdU and CCK-8 assays, we observed dose-dependent changes in cell proliferation. Interestingly, UVA irradiation at these doses of 0.75, 1.5 and 3 J/cm2 did not significantly induce ROS production. Our study further delves into the role of OPN3, a photosensitive receptor, in melanoma progression. Following UVA exposure, an increase in OPN3 expression was observed in melanoma cells lines A375 and MV3, indicating its role as a UVA-sensitive sensor and its influence on cell proliferation. Additionally, UVA-induced calcium flux in two melanoma cells lines pointed to a calcium-dependent G protein-coupled pathway in melanoma proliferation, mediated by OPN3 and not reliant on ROS. This research sheds light on the mechanism of UVA-induced melanoma progression, underscoring OPN3 as a pivotal regulator and advancing our understanding of UVA's interaction with opsins in melanoma progression.

UVA 辐射是导致黑色素瘤恶化的主要风险因素,其部分作用是通过活性氧(ROS)来实现的。目前还不完全清楚 ROS 在促使皮肤黑色素瘤形成侵袭性表型方面所起的作用,以及这种作用是否是通过对光敏感的 G 蛋白偶联受体 opsins(OPNs)产生的。本研究重点关注 UVA 辐射对黑色素瘤细胞增殖的影响,并特别强调 OPN3。通过研究 A375 和 MV3 细胞系对不同 UVA 剂量(0.75-9 J/cm2)的双相反应,并使用 EdU 和 CCK-8 检测法,我们观察到细胞增殖的变化与剂量有关。有趣的是,0.75、1.5 和 3 J/cm2 剂量的 UVA 照射并没有显著诱导 ROS 的产生。我们的研究进一步探讨了光敏受体 OPN3 在黑色素瘤进展中的作用。暴露于 UVA 后,在黑色素瘤细胞系 A375 和 MV3 中观察到 OPN3 的表达增加,这表明它作为 UVA 敏感传感器的作用及其对细胞增殖的影响。此外,两种黑色素瘤细胞系中 UVA 诱导的钙通量表明,黑色素瘤增殖过程中的钙依赖性 G 蛋白偶联通路由 OPN3 介导,而不依赖于 ROS。这项研究揭示了 UVA 诱导黑色素瘤发展的机制,强调了 OPN3 是一个关键的调节因子,并加深了我们对 UVA 与黑色素瘤发展过程中的蛋白相互作用的理解。
{"title":"UVA Irradiation Promotes Melanoma Cell Proliferation Mediated by OPN3 Independently of ROS Production","authors":"Yulei Zhang,&nbsp;Wen Zeng,&nbsp;Wei Zhang,&nbsp;Yu Wang,&nbsp;Shuqi Jin,&nbsp;Ting Liu,&nbsp;Huanhuan Luo,&nbsp;Hongguang Lu","doi":"10.1111/pcmr.13206","DOIUrl":"10.1111/pcmr.13206","url":null,"abstract":"<p>UVA radiation, a primary risk factor in melanoma progression, partly acts through the mediation of reactive oxygen species (ROS). The role of ROS in driving cutaneous melanoma toward an invasive phenotype and whether it occurs through opsins (OPNs), which are photosensitive G protein-coupled receptors, is not fully understood. This study focuses on the impact of UVA radiation on melanoma cell proliferation, with a special emphasis on OPN3. Investigating the biphasic response to various UVA doses (0.75–9 J/cm<sup>2</sup>) in A375 and MV3 cell lines, and using EdU and CCK-8 assays, we observed dose-dependent changes in cell proliferation. Interestingly, UVA irradiation at these doses of 0.75, 1.5 and 3 J/cm<sup>2</sup> did not significantly induce ROS production. Our study further delves into the role of OPN3, a photosensitive receptor, in melanoma progression. Following UVA exposure, an increase in OPN3 expression was observed in melanoma cells lines A375 and MV3, indicating its role as a UVA-sensitive sensor and its influence on cell proliferation. Additionally, UVA-induced calcium flux in two melanoma cells lines pointed to a calcium-dependent G protein-coupled pathway in melanoma proliferation, mediated by OPN3 and not reliant on ROS. This research sheds light on the mechanism of UVA-induced melanoma progression, underscoring OPN3 as a pivotal regulator and advancing our understanding of UVA's interaction with opsins in melanoma progression.</p>","PeriodicalId":219,"journal":{"name":"Pigment Cell & Melanoma Research","volume":"38 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11681839/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142542418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bay 11-7082, an NF-κB Inhibitor, Prevents Post-Inflammatory Hyperpigmentation Through Inhibition of Inflammation and Melanogenesis NF-κB 抑制剂 Bay 11-7082 可通过抑制炎症和黑色素生成来预防炎症后色素沉着。
IF 3.9 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-27 DOI: 10.1111/pcmr.13207
Juwon Moon, Ik Jun Moon, Hoyong Hyun, Jae Min Yoo, Seung Hyun Bang, Youngsup Song, Sung Eun Chang

Post-inflammatory hyperpigmentation (PIH) is a very common disorder of cutaneous hyperpigmentation, which poses a persistent management challenge in the fields of dermatology and esthetics. This study was designed to explore the anti-melanogenic and anti-inflammatory effects of Bay 11-7082, an NF-κB inhibitor, using small-molecule screening, to determine its potential application for PIH prevention. The molecular mechanisms were investigated in vitro and ex vivo in epidermis-humanized mice using melanin content, RT-PCR, and immunoblotting. Bay 11-7082 suppressed proinflammatory cytokines and ameliorated 2,4-dinitrofluorobenzene (DNFB)-induced contact dermatitis on day 15. The suppression of melanin synthesis by Bay 11-7082 was attributed to the reduction of MITF, which was induced by extracellular signal-regulated kinase activation. Bay 11-7082 reduced epidermal melanin accumulation in UVB-stimulated ex vivo human epidermis as well as in the ear and tail skin of K14-stem cell factor (SCF) transgenic mice. Topical administration of Bay 11-7082 improved PIH on day 35 in the post-DNFB dorsal skin of K14-SCF transgenic mice. In conclusion, Bay 11-7082 can be considered a promising candidate for the development of a preventive topical agent for PIH.

炎症后色素沉着(PIH)是一种非常常见的皮肤色素沉着疾病,在皮肤病学和美容领域一直是一个管理难题。本研究旨在通过小分子筛选,探索一种 NF-κB 抑制剂 Bay 11-7082 的抗黑色素生成和抗炎作用,以确定其在预防 PIH 方面的潜在应用。研究人员利用黑色素含量、RT-PCR 和免疫印迹技术,对表皮人源化小鼠的体外和体内分子机制进行了研究。Bay 11-7082抑制了促炎细胞因子,并在第15天改善了2,4-二硝基氟苯(DNFB)诱导的接触性皮炎。Bay 11-7082 抑制黑色素合成的原因是细胞外信号调节激酶活化诱导的 MITF 减少。Bay 11-7082 可减少 UVB 刺激的体外人体表皮以及 K14 干细胞因子(SCF)转基因小鼠耳部和尾部皮肤的表皮黑色素积累。外用 Bay 11-7082 在第 35 天改善了 K14-SCF 转基因小鼠 DNFB 后背侧皮肤的 PIH。总之,Bay 11-7082 可被视为开发 PIH 预防性局部用药的理想候选药物。
{"title":"Bay 11-7082, an NF-κB Inhibitor, Prevents Post-Inflammatory Hyperpigmentation Through Inhibition of Inflammation and Melanogenesis","authors":"Juwon Moon,&nbsp;Ik Jun Moon,&nbsp;Hoyong Hyun,&nbsp;Jae Min Yoo,&nbsp;Seung Hyun Bang,&nbsp;Youngsup Song,&nbsp;Sung Eun Chang","doi":"10.1111/pcmr.13207","DOIUrl":"10.1111/pcmr.13207","url":null,"abstract":"<div>\u0000 \u0000 <p>Post-inflammatory hyperpigmentation (PIH) is a very common disorder of cutaneous hyperpigmentation, which poses a persistent management challenge in the fields of dermatology and esthetics. This study was designed to explore the anti-melanogenic and anti-inflammatory effects of Bay 11-7082, an NF-κB inhibitor, using small-molecule screening, to determine its potential application for PIH prevention. The molecular mechanisms were investigated in vitro and ex vivo in epidermis-humanized mice using melanin content, RT-PCR, and immunoblotting. Bay 11-7082 suppressed proinflammatory cytokines and ameliorated 2,4-dinitrofluorobenzene (DNFB)-induced contact dermatitis on day 15. The suppression of melanin synthesis by Bay 11-7082 was attributed to the reduction of MITF, which was induced by extracellular signal-regulated kinase activation. Bay 11-7082 reduced epidermal melanin accumulation in UVB-stimulated ex vivo human epidermis as well as in the ear and tail skin of K14-stem cell factor (SCF) transgenic mice. Topical administration of Bay 11-7082 improved PIH on day 35 in the post-DNFB dorsal skin of K14-SCF transgenic mice. In conclusion, Bay 11-7082 can be considered a promising candidate for the development of a preventive topical agent for PIH.</p>\u0000 </div>","PeriodicalId":219,"journal":{"name":"Pigment Cell & Melanoma Research","volume":"38 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142491757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-Dose Baricitinib Plus Narrow-Band Ultraviolet B for the Treatment of Progressive Non-Segmental Vitiligo: A Prospective, Controlled, Open-Label Study 低剂量巴利替尼加窄带紫外线 B 治疗进展期非节段性白癜风:一项前瞻性、对照、开放标签研究。
IF 3.9 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-23 DOI: 10.1111/pcmr.13209
Zhonghui Hu, Lu Lu, Jindi Feng, Hongbin Song, Shiyu Zhang, Lu Yang, Yuehua Liu, Tao Wang

Vitiligo is a chronic autoimmune disease, and current treatments for vitiligo have limited efficacy. Janus kinase (JAK) inhibitors could offer new therapeutic options. To evaluate the efficacy and safety of baricitinib, an oral JAK1/2 inhibitor, combined with narrow-band ultraviolet B (NB-UVB) in vitiligo treatment. This prospective, controlled, open-label study included adults with progressive non-segmental vitiligo (NSV). Patients were assigned to combination therapy with baricitinib 2 mg daily and NB-UVB three times a week or NB-UVB alone three times a week (control). The primary endpoint was the proportion of patients achieving 50% or greater improvement from baseline in the total Vitiligo Area Scoring Index (T-VASI50) at week 16. Of the 33 patients (mean age, 34.1 years; 27.3% women) who completed the study, 12 of 17 (70.6%) patients in the combination group and 2 of 16 (12.5%) in the control group had a T-VASI50 response at week 16 (relative risk [RR] = 5.6; 95% CI = 1.5–21.4; p = 0.001). Adverse events were minor, including erythema, mild blister after phototherapy and acne. Combination therapy with low-dose baricitinib and NB-UVB was effective and well tolerated in adults with progressive NSV.

白癜风是一种慢性自身免疫性疾病,目前治疗白癜风的方法疗效有限。Janus激酶(JAK)抑制剂可提供新的治疗选择。目的是评估口服JAK1/2抑制剂巴利昔尼(baricitinib)联合窄带紫外线B(NB-UVB)治疗白癜风的疗效和安全性。这项前瞻性、对照、开放标签研究纳入了进展期非节段性白癜风(NSV)成人患者。患者被分配接受巴利昔尼(baricitinib)每天2毫克、NB-UVB每周三次的联合治疗,或仅接受NB-UVB每周三次的治疗(对照组)。主要终点是在第16周时,白癜风总面积评分指数(T-VASI50)比基线提高50%或以上的患者比例。在完成研究的 33 名患者(平均年龄 34.1 岁;27.3% 为女性)中,联合用药组 17 名患者中有 12 名(70.6%)在第 16 周时对 T-VASI50 有反应,对照组 16 名患者中有 2 名(12.5%)(相对风险 [RR] = 5.6;95% CI = 1.5-21.4;P = 0.001)。不良反应较轻,包括红斑、光疗后轻度水疱和痤疮。小剂量巴利昔尼和NB-UVB联合疗法对进展期NSV成人患者有效且耐受性良好。
{"title":"Low-Dose Baricitinib Plus Narrow-Band Ultraviolet B for the Treatment of Progressive Non-Segmental Vitiligo: A Prospective, Controlled, Open-Label Study","authors":"Zhonghui Hu,&nbsp;Lu Lu,&nbsp;Jindi Feng,&nbsp;Hongbin Song,&nbsp;Shiyu Zhang,&nbsp;Lu Yang,&nbsp;Yuehua Liu,&nbsp;Tao Wang","doi":"10.1111/pcmr.13209","DOIUrl":"10.1111/pcmr.13209","url":null,"abstract":"<p>Vitiligo is a chronic autoimmune disease, and current treatments for vitiligo have limited efficacy. Janus kinase (JAK) inhibitors could offer new therapeutic options. To evaluate the efficacy and safety of baricitinib, an oral JAK1/2 inhibitor, combined with narrow-band ultraviolet B (NB-UVB) in vitiligo treatment. This prospective, controlled, open-label study included adults with progressive non-segmental vitiligo (NSV). Patients were assigned to combination therapy with baricitinib 2 mg daily and NB-UVB three times a week or NB-UVB alone three times a week (control). The primary endpoint was the proportion of patients achieving 50% or greater improvement from baseline in the total Vitiligo Area Scoring Index (T-VASI50) at week 16. Of the 33 patients (mean age, 34.1 years; 27.3% women) who completed the study, 12 of 17 (70.6%) patients in the combination group and 2 of 16 (12.5%) in the control group had a T-VASI50 response at week 16 (relative risk [RR] = 5.6; 95% CI = 1.5–21.4; <i>p</i> = 0.001). Adverse events were minor, including erythema, mild blister after phototherapy and acne. Combination therapy with low-dose baricitinib and NB-UVB was effective and well tolerated in adults with progressive NSV.</p>","PeriodicalId":219,"journal":{"name":"Pigment Cell & Melanoma Research","volume":"38 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11681843/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142491758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
25th Annual meeting of the European Society for Pigment Cell Research, Marseille, France 第 25 届欧洲色素细胞研究学会年会,法国马赛
IF 3.9 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-14 DOI: 10.1111/pcmr.13192
{"title":"25th Annual meeting of the European Society for Pigment Cell Research, Marseille, France","authors":"","doi":"10.1111/pcmr.13192","DOIUrl":"https://doi.org/10.1111/pcmr.13192","url":null,"abstract":"","PeriodicalId":219,"journal":{"name":"Pigment Cell & Melanoma Research","volume":"37 5","pages":"713-740"},"PeriodicalIF":3.9,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142435521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PASPCR 2024 Annual Meeting, New York, NY PASPCR 2024 年年会,纽约州纽约市
IF 3.9 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-14 DOI: 10.1111/pcmr.13191
{"title":"PASPCR 2024 Annual Meeting, New York, NY","authors":"","doi":"10.1111/pcmr.13191","DOIUrl":"https://doi.org/10.1111/pcmr.13191","url":null,"abstract":"","PeriodicalId":219,"journal":{"name":"Pigment Cell & Melanoma Research","volume":"37 5","pages":"693-712"},"PeriodicalIF":3.9,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142435520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pigment Cell & Melanoma Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1